Patents by Inventor Samanthi A Perera

Samanthi A Perera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combinations of PD-1 antagonists and benzo [b] thiophene STING agonists for cancer treatment
    Patent number: 11312772
    Abstract: Therapeutic combinations that comprise at least one antagonist of the Programmed Death 1 receptor (PD-1) and at least one benzo[b]thiophene compound that activates the Stimulator of Interferon Genes (STING) pathway are disclosed herein. Also disclosed is the use of such therapeutic combinations for the treatment of cancers.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: April 26, 2022
    Assignee: MERCK SHARP & DOHME CORP.
    Inventors: Saso Cemerski, Jared N. Cumming, Johnny E. Kopinja, Samanthi A. Perera, Benjamin Wesley Trotter, Archie Ngai-Chiu Tse
  • Benzo[b]thiophene STING agonists for cancer treatment
    Patent number: 11285131
    Abstract: Therapies comprising administering at least one benzo[b]thiophene compound that activates the Stimulator of Interferon Genes (STING) pathway, and the use of such therapies in the treatment of cell-proliferation disorders such as cancer, are disclosed herein.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: March 29, 2022
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Saso Cemerski, Jared N. Cumming, Johnny E. Kopinja, Samanthi A. Perera, Benjamin Wesley Trotter, Archie Ngai-Chiu Tse
  • Combinations of PD-1 Antagonists and Benzo[b]thiophene STING Agonists for Cancer Treatment
    Publication number: 20210130466
    Abstract: Therapeutic combinations that comprise at least one antagonist of the Programmed Death 1 receptor (PD-1) and at least one benzo[b]thiophene compound that activates the Stimulator of Interferon Genes (STING) pathway are disclosed herein. Also disclosed is the use of such therapeutic combinations for the treatment of cancers.
    Type: Application
    Filed: July 30, 2018
    Publication date: May 6, 2021
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Saso CEMERSKI, Jared N. CUMMING, Johnny E. KOPINJA, Samanthi A. PERERA, Benjamin Wesley TROTTER, Archie Ngai-Chiu TSE
  • Benzo[b]thiophene STING Agonists for Cancer Treatment
    Publication number: 20200330427
    Abstract: Therapies comprising administering at least one benzo[b]thiophene compound that activates the Stimulator of Interferon Genes (STING) pathway, and the use of such therapies in the treatment of cell-proliferation disorders such as cancer, are disclosed herein.
    Type: Application
    Filed: July 30, 2018
    Publication date: October 22, 2020
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Saso CEMERSKI, Jared N. CUMMING, Johnny E. KOPINJA, Samanthi A. PERERA, Benjamin Wesley TROTTER, Archie Ngai-Chiu TSE
  • CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT
    Publication number: 20200113924
    Abstract: Therapies comprising administering at least one cyclic dinucleotide compound that activates the Stimulator of Interferon Genes (STING) pathway, and the use of such therapies in the treatment of cell-proliferation disorders such as cancer, are disclosed herein.
    Type: Application
    Filed: December 15, 2017
    Publication date: April 16, 2020
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Saso Cemerski, Jared N. Cumming, Lauren M. Flateland, Johnny E. Kopinja, Yanhong Ma, Samanthi A. Perera, Benjamin Wesley Trotter, Archie Ngai-Chiu Tse
  • COMBINATIONS OF PD-1 ANTAGONISTS AND CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT
    Publication number: 20190328762
    Abstract: Therapeutic combinations that comprise at least one antagonist of the Programmed Death 1 receptor (PD-1) and at least one cyclic dinucleotide compound that activates the Stimulator of Interferon Genes (STING) pathway are disclosed herein. Also disclosed is the use of such therapeutic combinations for the treatment of cancers.
    Type: Application
    Filed: December 15, 2017
    Publication date: October 31, 2019
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Saso Cemerski, Jared N Cumming, Johnny E Kopinja, Yanhong Ma, Samanthi A Perera, Benjamin Wesley Trotter, Archie Ngai-Chiu Tse